We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,966 results
  1. Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac

    Corona virus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has affected the whole world....

    Zhangbiao Long, Suyu Jiang, ... **aofeng Shi in Frontiers of Medicine
    Article 03 July 2024
  2. Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

    Background

    Senecavirus A (SVA) causes an emerging vesicular disease (VD) with clinical symptoms indistinguishable from other vesicular diseases,...

    **yong Zhang, Peng Wang, ... Jicheng Han in BMC Veterinary Research
    Article Open access 06 March 2024
  3. Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews

    Background

    Influenza infection is a highly preventable transmissible viral disease associated with mild upper respiratory symptoms and more severe...

    Rodrigo Luiz Carregaro, Alessandra N. C. P. Roscani, ... Juliana Yukari K. Viscondi in BMC Infectious Diseases
    Article Open access 29 August 2023
  4. Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults

    Introduction

    Vaccination is a critical tool for preventing coronavirus disease 2019 (COVID-19) and influenza illnesses. Coadministration of the...

    Louise Murdoch, Karen Quan, ... Joanna Wojciechowska in Infectious Diseases and Therapy
    Article Open access 12 September 2023
  5. Efficacy of H2O2 inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine in mice

    Background

    Bovine viral diarrhea (BVD) is an acute febrile infectious disease caused by the bovine viral diarrhea virus (BVDV), which has brought huge...

    Cunyuan Li, **ming Yu, ... Shengwei Hu in BMC Veterinary Research
    Article Open access 03 February 2024
  6. Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial

    Considering that neutralizing antibody levels induced by two doses of the inactivated vaccine decreased over time and had fallen to low levels by 6...

    Tao Huang, Qianqian Hu, ... Lihui Gong in BMC Infectious Diseases
    Article Open access 19 April 2024
  7. Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3

    Respiratory diseases constitute a major health problem for ruminants, resulting in considerable economic losses throughout the world. Parainfluenza...

    Yanhua Ma, Jialei Wang, ... Wei Wang in Veterinary Research
    Article Open access 27 June 2024
  8. Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection

    Introduction

    The purpose of this study was to investigate whether the inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine...

    **aowei Zhang, Yifei Li, ... Guihong Wang in Rheumatology and Therapy
    Article Open access 04 January 2024
  9. Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design

    Background

    Evidence on the effectiveness of influenza vaccination in the elderly is limited, and results are controversial. There are also few reports...

    Tianchi Yang, Ling Tang, ... Jifang Zhou in BMC Geriatrics
    Article Open access 07 May 2024
  10. Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines

    Vaccines have proven effective in protecting populations against COVID-19, including the recombinant COVID-19 vaccine (Sf9 cells), the first approved...

    Wenxin Luo, Jiadi Gan, ... Lei Chen in Signal Transduction and Targeted Therapy
    Article Open access 14 February 2024
Did you find what you were looking for? Share feedback.